Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 2Suspended 1

Sponsor Class

OTHER 1NIH 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 522Neoplasms 470Carcinoma, Non-Small-Cell Lung 393Prostatic Neoplasms 302Colorectal Neoplasms 296Lung Neoplasms 259Neoplasm Metastasis 217Ovarian Neoplasms 198Leukemia, Myeloid, Acute 194Pancreatic Neoplasms 185Multiple Myeloma 172Squamous Cell Carcinoma of Head and Neck 133Recurrence 132Stomach Neoplasms 129Brain Neoplasms 126Melanoma 123Carcinoma, Hepatocellular 123Endometrial Neoplasms 120Glioblastoma 118Triple Negative Breast Neoplasms 111Precursor Cell Lymphoblastic Leukemia-Lymphoma 105Hematologic Neoplasms 99Head and Neck Neoplasms 97Carcinoma, Renal Cell 96Lymphoma 93Urinary Bladder Neoplasms 90Sarcoma 90Glioma 88Lymphoma, Large B-Cell, Diffuse 81Small Cell Lung Carcinoma 80

Interventions

siltuximab 1erenumab 1Saline Solution 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Neurilemmoma × 90 days × Clear all
NCT00598351 2026-06-05

Natural History Study of Patients With Neurofibromatosis Type 2

National Institutes of Health Clinical Center (CC)

Recruiting
269 enrolled
CNS

Ependymoma, Meningioma, Neurilemmoma, Neuroma, Acoustic, Spinal Cord Neoplasms, Neurofibromatoses

NCT05684692 2026-04-23

Screening Trial for Pain Relief in Schwannomatosis (STARFISH)

Massachusetts General Hospital

Phase 2 Recruiting
40 enrolled

Schwannomatosis, Neurilemmoma, Pain, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡